tirzepatide safety Mechanism of Weight Loss & Blood Sugar Control Efficacy and Safety of Tirzepatide

Notably, ANN and RF models exhibit similar performance in many measures

Based on the estimated 3.8 million Part D enrollees eligible for the Medicare GLP-1 Bridge as of 2023, if 10% to 25% participate in Bridge from when the program launches in July 2026 and fill a prescription each month for the 18-month duration of the program, the cost to Medicare would be $1.3 billion to $3.3 billion (at a net monthly cost of $245 minus the $50 beneficiary copay)

Pan et al., 2013a

Second, although standardized definitions for MACEs and composite renal outcomes were applied in this analysis, heterogeneity exists in the definitions of these endpoints across the included trials (e.g., variations in component events or eGFR decline thresholds), which should be considered when interpreting the pooled estimates